Last reviewed · How we verify

NCT04326699

Bilateral Sacroiliac Joint (SIJ) Injection in Lumbar Disc Prolapse

Completed NA Last updated 4 November 2020
What this trial tests

NA trial testing Bilateral SIJ injection in Lumbar Disc Herniation in 86 participants. Completed in 15 October 2020.

Timeline
15 March 2020
Primary endpoint
15 September 2020
15 October 2020

Quick facts

Lead sponsorSohag University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment86
Start date15 March 2020
Primary completion15 September 2020
Estimated completion15 October 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

18 and older, any sex, with Lumbar Disc Herniation or Sciatica. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bilateral sacroiliac joint injection in symptomatic lumbar disc prolapse under ultrasound guidance and studying the effect of this technique on pain, spine mobility and activity of daily living.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lumbar Disc Herniation

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04326699.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing